胸腺肽联合阿德福韦酯治疗慢性乙型肝炎60例观察

目的探索抑制乙肝病毒复制,治疗慢性乙型肝炎安全有效的治疗方法。方法采取随机分组,2组对比的方法。抽取空腹血化验肝功能、乙肝病毒标志物及乙肝病毒复制指标,用卡方检验。结果治疗组ALT、TBIL复常率及HBV-DNA转阴率高于对照组,但差异无显著性意义(P>0.05);治疗组总有效率高于对照组(P<0.05)。结论胸腺肽联合阿德福韦酯是抑制乙肝病毒复制、治疗慢性乙型肝炎安全有效的方法。

Objective To explore the safe and effective treatment to inhibit hepatitis B virus replication and treat chronic hepatitis B.Methods A randomized comparison of two.Get fasting blood liver function tests,hepatitis B virus markers and hepatitis B virus replication index and then test with chi-square.Results The ALT,TBIL＇s recovery rate and HBV-DNA negative rate is higher than the control group,but the difference was not significant（P0.05）;the efficiency of the treatment group was higher than the control group（P0.05）.Conclusion Adefovir dipivoxil Thymosin hepatitis B virus replication is safe and effective method to inhibit hepatitis B virus replication and treat chronic hepatitis B.